| ZoBio is developing innovative methods using
Nuclear Magnetic Resonance to screen compound libraries for binding
to a broad range of pharmacological targets.
Our aim is to be capable of rapidly generating high affinity,
high specificity lead compounds with optimal drug-like properties
for targets with great pharmacological value but for which developing
drugs using presently available technologies would be difficult
or impossible. |
